Trial Summary
What is the purpose of this trial?Objectives To 1) examine the ability of the STRIDE (Simplification of Treatment Regimens and Individualized Diabetes Education) educational program to increase deprescribing of high hypoglycemia risk glucose-lowering medications (HRMs) among long term care facility (LTCF) residents with ADRD, 2) assess key implementation constructs (secondary outcomes) of the STRIDE program, including acceptability, appropriateness, and feasibility, and 3) validate the primary HRM use outcome measure.
Eligibility Criteria
This trial is for clinical staff at long-term care facilities, including doctors, physician assistants, nurse practitioners, and clinical pharmacists. They must have participated in the STRIDE program aimed at educating on deprescribing diabetes medication for residents with Alzheimer's.Inclusion Criteria
This criterion is not related to a clinical trial exclusion criteria. It appears to be related to the targeted providers for a specific program. If you need help with clinical trial exclusion criteria, please provide additional information.
Staff who took part in the STRIDE program (Providers doing stakeholder exit interviews).
Exclusion Criteria
Consistent with the pragmatic nature of the trial, there are no exclusion criteria.
Participant Groups
The STRIDE educational program is being tested to see if it helps reduce the use of diabetes medications that carry a high risk of causing low blood sugar in elderly patients with dementia. The study will also evaluate how well the program is accepted and implemented by healthcare providers.
1Treatment groups
Experimental Treatment
Group I: STRIDE InterventionExperimental Treatment1 Intervention
Educational intervention for clinicians
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Joslin Diabetes CenterBoston, MA
Loading ...
Who Is Running the Clinical Trial?
Joslin Diabetes CenterLead Sponsor
Brown UniversityCollaborator
Theoria MedicalCollaborator